Author

Rokeya Tasneen

Johns Hopkins University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Organism:non-human primate· 1

Frequent Co-Authors

Eric L. NuermbergeriD· 3 shared Si‐Yang Li· 2 shared Addis Yilma· 1 shared Adolfo García-Pérez· 1 shared Alannah D. Taylor· 1 shared Alfonso Mendoza-LosanaiD· 1 shared Amanda R. MaxwelliD· 1 shared Amit KaushikiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Eric L. NuermbergerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Therapeutic DNA Vaccine Targeting Mycobacterium tuberculosis Persisters Shortens Curative Tuberculosis Treatment

Styliani Karanika, Tianyin Wang, Addis Yilma, Jennie Ruelas Castillo, James T. Gordy, Hannah Bailey, Darla Quijada, Kaitlyn Fessler, Rokeya Tasneen, Elisa M. Rouse Salcido, Farah Shamma, Harley T. Harris, Fengyixin Chen, Rowan E. Bates, Heemee Ton, , Petros C. Karakousis

A DNA vaccine targeting Mtb persisters reduces TB treatment duration in mice and elicits similar immune responses in macaques.

Journal of Clinical Investigation · Feb 3, 2026Peer-reviewedImmunology

Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis

Lourdes Encinas, Si‐Yang Li, Joaquín Rullás, Rokeya Tasneen, Sandeep K. Tyagi, Heena Soni, Adolfo García-Pérez, Jin Lee, Rubén González del Río, Jaime de Mercado, Verónica Sousa, Izidor Sosič, Stanislav Gobec, Alfonso Mendoza-Losana, Paul J. Converse, , Eric L. Nuermberger

This study evaluates direct inhibitors of InhA (DIIs) for tuberculosis treatment, showing their efficacy comparable to isoniazid and their potential in new drug regimens.

Antimicrobial Agents and Chemotherapy · Sep 30, 2024Peer-reviewedPharmacology & Toxicology

Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models

Henry E. Pertinez, Amit Kaushik, Paul Curley, Usman Arshad, Eman El‐Khateeb, Si‐Yang Li, Rokeya Tasneen, Joanne Sharp, Edyta Kijak, Joanne Herriott, Megan Neary, Michaël Noë, Charles W. Flexner, Eric L. Nuermberger, Andrew Owen, Nicole C. Ammerman

This study evaluates how hyaluronidase affects the release and pharmacokinetics of a long-acting injectable drug in mice and rats.

bioRxiv · Mar 3, 2024 · PreprintPharmacology & Toxicology